321 related articles for article (PubMed ID: 24530272)
1. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients.
Belzil VV; Bauer PO; Gendron TF; Murray ME; Dickson D; Petrucelli L
Brain Res; 2014 Oct; 1584():15-21. PubMed ID: 24530272
[TBL] [Abstract][Full Text] [Related]
2. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood.
Belzil VV; Bauer PO; Prudencio M; Gendron TF; Stetler CT; Yan IK; Pregent L; Daughrity L; Baker MC; Rademakers R; Boylan K; Patel TC; Dickson DW; Petrucelli L
Acta Neuropathol; 2013 Dec; 126(6):895-905. PubMed ID: 24166615
[TBL] [Abstract][Full Text] [Related]
3. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS.
Gendron TF; Bieniek KF; Zhang YJ; Jansen-West K; Ash PE; Caulfield T; Daughrity L; Dunmore JH; Castanedes-Casey M; Chew J; Cosio DM; van Blitterswijk M; Lee WC; Rademakers R; Boylan KB; Dickson DW; Petrucelli L
Acta Neuropathol; 2013 Dec; 126(6):829-44. PubMed ID: 24129584
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients.
Xi Z; Rainero I; Rubino E; Pinessi L; Bruni AC; Maletta RG; Nacmias B; Sorbi S; Galimberti D; Surace EI; Zheng Y; Moreno D; Sato C; Liang Y; Zhou Y; Robertson J; Zinman L; Tartaglia MC; St George-Hyslop P; Rogaeva E
Hum Mol Genet; 2014 Nov; 23(21):5630-7. PubMed ID: 24908669
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier.
Russ J; Liu EY; Wu K; Neal D; Suh E; Irwin DJ; McMillan CT; Harms MB; Cairns NJ; Wood EM; Xie SX; Elman L; McCluskey L; Grossman M; Van Deerlin VM; Lee EB
Acta Neuropathol; 2015 Jan; 129(1):39-52. PubMed ID: 25388784
[TBL] [Abstract][Full Text] [Related]
6. Methylation of C9orf72 expansion reduces RNA foci formation and dipeptide-repeat proteins expression in cells.
Bauer PO
Neurosci Lett; 2016 Jan; 612():204-209. PubMed ID: 26690922
[TBL] [Abstract][Full Text] [Related]
7. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.
Liu EY; Russ J; Wu K; Neal D; Suh E; McNally AG; Irwin DJ; Van Deerlin VM; Lee EB
Acta Neuropathol; 2014 Oct; 128(4):525-41. PubMed ID: 24806409
[TBL] [Abstract][Full Text] [Related]
8. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
9. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.
Gijselinck I; Van Mossevelde S; van der Zee J; Sieben A; Engelborghs S; De Bleecker J; Ivanoiu A; Deryck O; Edbauer D; Zhang M; Heeman B; Bäumer V; Van den Broeck M; Mattheijssens M; Peeters K; Rogaeva E; De Jonghe P; Cras P; Martin JJ; de Deyn PP; Cruts M; Van Broeckhoven C
Mol Psychiatry; 2016 Aug; 21(8):1112-24. PubMed ID: 26481318
[TBL] [Abstract][Full Text] [Related]
10. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients.
Xi Z; Zhang M; Bruni AC; Maletta RG; Colao R; Fratta P; Polke JM; Sweeney MG; Mudanohwo E; Nacmias B; Sorbi S; Tartaglia MC; Rainero I; Rubino E; Pinessi L; Galimberti D; Surace EI; McGoldrick P; McKeever P; Moreno D; Sato C; Liang Y; Keith J; Zinman L; Robertson J; Rogaeva E
Acta Neuropathol; 2015 May; 129(5):715-27. PubMed ID: 25716178
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanisms of Neurodegeneration Related to
Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
[TBL] [Abstract][Full Text] [Related]
12. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72.
Konno T; Shiga A; Tsujino A; Sugai A; Kato T; Kanai K; Yokoseki A; Eguchi H; Kuwabara S; Nishizawa M; Takahashi H; Onodera O
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):398-401. PubMed ID: 23012445
[TBL] [Abstract][Full Text] [Related]
13. Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.
Glasmacher SA; Wong C; Pearson IE; Pal S
JAMA Neurol; 2020 Mar; 77(3):367-376. PubMed ID: 31738367
[TBL] [Abstract][Full Text] [Related]
14. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion.
Waite AJ; Bäumer D; East S; Neal J; Morris HR; Ansorge O; Blake DJ
Neurobiol Aging; 2014 Jul; 35(7):1779.e5-1779.e13. PubMed ID: 24559645
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72.
Savica R; Adeli A; Vemuri P; Knopman DS; Dejesus-Hernandez M; Rademakers R; Fields JA; Whitwell J; Jack CR; Lowe V; Petersen RC; Boeve BF
Arch Neurol; 2012 Sep; 69(9):1164-9. PubMed ID: 22637471
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
[TBL] [Abstract][Full Text] [Related]
17. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.
Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M
Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838
[TBL] [Abstract][Full Text] [Related]
18. Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration.
Suh E; Lee EB; Neal D; Wood EM; Toledo JB; Rennert L; Irwin DJ; McMillan CT; Krock B; Elman LB; McCluskey LF; Grossman M; Xie SX; Trojanowski JQ; Van Deerlin VM
Acta Neuropathol; 2015 Sep; 130(3):363-72. PubMed ID: 26022924
[TBL] [Abstract][Full Text] [Related]
19. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
[TBL] [Abstract][Full Text] [Related]
20. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
